Twice-Daily Brinzolamide/Brimonidine Fixed Combination versus Brinzolamide or Brimonidine in Open-Angle Glaucoma or Ocular Hypertension (vol 121, pg 2348, 2014)

被引：0
|
作者：
Aung, T.
Laganovska, G.
Hernandez Paredes, T. J.
机构：
来源：
OPHTHALMOLOGY | 2015年 / 122卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：2149 / 2149
页数：1
相关论文
共 50 条
  • [1] Twice-Daily Brinzolamide/Brimonidine Fixed Combination versus Brinzolamide or Brimonidine in Open-Angle Glaucoma or Ocular Hypertension
    Aung, Tin
    Laganovska, Guna
    Hernandez Paredes, Tania Josefina
    Branch, James D.
    Tsorbatzoglou, Alexis
    Goldberg, Ivan
    OPHTHALMOLOGY, 2014, 121 (12) : 2348 - 2355
  • [2] Randomized Trial of Brinzolamide/Brimonidine Versus Brinzolamide Plus Brimonidine for Open-Angle Glaucoma or Ocular Hypertension
    Gandolfi, Stefano A.
    Lim, John
    Cristina Sanseau, Ana
    Parra Restrepo, Juan Camilo
    Hamacher, Thomas
    ADVANCES IN THERAPY, 2014, 31 (12) : 1213 - 1227
  • [3] Randomized Trial of Brinzolamide/Brimonidine Versus Brinzolamide Plus Brimonidine for Open-Angle Glaucoma or Ocular Hypertension
    Stefano A. Gandolfi
    John Lim
    Ana Cristina Sanseau
    Juan Camilo Parra Restrepo
    Thomas Hamacher
    Advances in Therapy, 2014, 31 : 1213 - 1227
  • [4] Clinical effectiveness of brinzolamide 1%-brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertension
    Sharma, Sourabh
    Trikha, Sameer
    Perera, Shamira A.
    Aung, Tin
    CLINICAL OPHTHALMOLOGY, 2015, 9 : 2201 - 2207
  • [5] Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
    Wang, Ningli
    Lu, Da-Wen
    Pan, Yingzi
    Astakhov, Yury
    Iureva, Tatyana
    Adewale, Adeniyi
    Walker, Thomas M.
    CLINICAL OPHTHALMOLOGY, 2020, 14 : 221 - 230
  • [6] Brinzolamide/Brimonidine: A Review of Its Use in Patients with Open-Angle Glaucoma or Ocular Hypertension
    Sarah L. Greig
    Emma D. Deeks
    Drugs & Aging, 2015, 32 : 251 - 260
  • [7] Brinzolamide/Brimonidine: A Review of Its Use in Patients with Open-Angle Glaucoma or Ocular Hypertension
    Greig, Sarah L.
    Deeks, Emma D.
    DRUGS & AGING, 2015, 32 (03) : 251 - 260
  • [8] Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension
    Topouzis, Fotis
    Goldberg, Ivan
    Bell, Katharina
    Tatham, Andrew J.
    Ridolfi, Antonia
    Hubatsch, Douglas
    Nicolela, Marcelo
    Denis, Phillipe
    Fabian Lerner, S.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2021, 31 (01) : 103 - 111
  • [9] Fixed-combination brinzolamide 1%/brimonidine 0.2% vs monotherapy with brinzolamide or brimonidine in patients with open-angle glaucoma or ocular hypertension: results of a pooled analysis of two phase 3 studies
    Realini, T.
    Nguyen, Q. H.
    Katz, G.
    DuBiner, H.
    EYE, 2013, 27 (07) : 841 - 847
  • [10] The Efficacy, Safety, and Satisfaction Associated with Switching from Brinzolamide or Brimonidine to Brinzolamide/Brimonidine in Open-Angle Glaucoma Patients
    Onoe, Hiromitsu
    Hirooka, Kazuyuki
    Nagayama, Mikio
    Mochizuki, Hideki
    Hirota, Atsushi
    Suzuki, Katsuyoshi
    Sagara, Takeshi
    Kiuchi, Yoshiaki
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (12):
12345